Literature DB >> 8332653

Major depression and phobias: the genetic and environmental sources of comorbidity.

K S Kendler1, M C Neale, R C Kessler, A C Heath, L J Eaves.   

Abstract

In a population based sample of 2163 personally interviewed female twins, substantial comorbidity was observed between DSM-III-R defined major depression (MD) and 4 subtypes of phobia: agoraphobia, social phobia, animal phobia and situational phobia. However, the level of comorbidity of MD with agoraphobia was much greater than that found with the other phobic subtypes. We concluded bivariate twin analyses to decompose the genetic and environmental sources of comorbidity between MD and the phobias. Our results suggest that a modest proportion of the genetic vulnerability to MD also influences the risk for all phobic subtypes, with the possible exception of situational phobias. Furthermore, the magnitude of comorbidity resulting from this shared genetic vulnerability is similar across the phobic subtypes. By contrast, the non-familial environmental experiences which predispose to depression substantially increase the vulnerability to agoraphobia, have a modest impact on the risk for social and situational phobias and no effect on the risk for animal phobias. The increased comorbidity between MD and agoraphobia results, nearly entirely, from individual-specific environmental risk factors for MD which also increase the risk for agoraphobia but not for other phobias.

Entities:  

Mesh:

Year:  1993        PMID: 8332653     DOI: 10.1017/s0033291700028464

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  Parental and peer predictors of social anxiety in youth.

Authors:  Candice C Festa; Golda S Ginsburg
Journal:  Child Psychiatry Hum Dev       Date:  2011-06

Review 2.  Behavioral genetics as a tool for developmental psychology: anxiety and depression in children and adolescents.

Authors:  T C Eley
Journal:  Clin Child Fam Psychol Rev       Date:  1999-03

3.  Strong genetic correlation between interview-assessed internalizing disorders and a brief self-report symptom scale.

Authors:  Line C Gjerde; Espen Røysamb; Nikolai Czajkowski; Ted Reichborn-Kjennerud; Ragnhild E Orstavik; Kenneth S Kendler; Kristian Tambs
Journal:  Twin Res Hum Genet       Date:  2011-02       Impact factor: 1.587

Review 4.  The genetic epidemiology of psychiatric disorders: a current perspective.

Authors:  K S Kendler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-01       Impact factor: 4.328

5.  Correlates of continued smoking versus cessation among survivors of smoking-related cancers.

Authors:  Carla J Berg; Akilah N Thomas; Ann C Mertens; Gillian L Schauer; Erika A Pinsker; Jasjit S Ahluwalia; Fadlo R Khuri
Journal:  Psychooncology       Date:  2012-04-09       Impact factor: 3.894

Review 6.  Genetic and environmental influences on psychiatric comorbidity: a systematic review.

Authors:  M Cerdá; A Sagdeo; J Johnson; S Galea
Journal:  J Affect Disord       Date:  2009-12-11       Impact factor: 4.839

7.  Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR).

Authors:  L J Strug; R Suresh; A J Fyer; A Talati; P B Adams; W Li; S E Hodge; T C Gilliam; M M Weissman
Journal:  Mol Psychiatry       Date:  2008-07-29       Impact factor: 15.992

Review 8.  Finding gene-environment interactions for phobias.

Authors:  Alice M Gregory; Jennifer Y F Lau; Thalia C Eley
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

9.  Depression and anxiety symptoms in mothers of newborns hospitalized on the neonatal intensive care unit.

Authors:  Lisa S Segre; Jennifer E McCabe; Rebecca Chuffo-Siewert; Michael W O'Hara
Journal:  Nurs Res       Date:  2014 Sep-Oct       Impact factor: 2.381

10.  Co-occurrence patterns of anxiety, depression and alcohol use disorders.

Authors:  Naomar Almeida-Filho; Ines Lessa; Lucélia Magalhães; Maria Jenny Araúho; Estela Aquino; Mari Jair de Jesus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.